sprite-preloader
Anzeige
Mehr »
Montag, 11.12.2017 Börsentäglich über 12.000 News von 573 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14:43Pfizer's breast cancer drug improves progression-free survival in Phase 3 trial
12:43NICE says lenvatinib should be available on NHS
09:43Aerogen Pharma, Lyomark Pharma to develop inhaled surfactant
08:43Lilly's Cyramza meets primary endpoint in phase 3 gastric cancer trial
FrRoche's lung cancer drug combo study shows improvement in progression-free survival
FrReport expects global cryotherapy market to cross $4bn by 2024
Frbluebird bio, TC BioPharm to develop Gamma Delta CAR T cell product candidates for cancer immunotherapy
FrGilead Sciences to acquire Cell Design Labs in $567m deal
DoGSK to invest £40m in genetic research under UK sector deal
DoFate Therapeutics, University of California San Diego launch CAR NK Cancer immunotherapy collaboration
DoCarmot, Amgen form drug discovery partnership
DoNovartis' Kisqali improves PFS in younger women with advanced breast cancer
MiJanssen's Imbruvica- rituximab combination meets primary end point in phase 3 study
MiArena, Everest Medicines partner for Ralinepag and Etrasimod in China
MiRealm Therapeutics doses first patient in phase 2 study of PR022 to treat atopic dermatitis
MiNovo Nordisk's Ozempic diabetic drug secures FDA approval
DiResearchers show aspirin added to cancer drug improves effectiveness
DiBlue Oak, PsychoGenics enter into drug discovery partnership
DiAbbVie's risankizumab meets all primary endpoints in fourth phase 3 psoriasis trial
04.12.Astellas Pharma acquires Mitobridge for $225m
04.12.I-Mab Biopharma partners with MorphoSys on cancer investigational medicine
04.12.Amgen's Repatha approved by FDA for heart attack and stroke prevention
01.12.resTORbio raises $40m from biotech and institutional investors
01.12.NIH and partners commence HIV vaccine efficacy trial
01.12.Indivior's Sublocade secures FDA approval to treat opioid use disorder